Tumor Biology

, Volume 34, Issue 6, pp 3357–3361 | Cite as

TCTP overexpression is associated with the development and progression of glioma

  • Xia Miao
  • Yong-Bin Chen
  • Sheng-Long Xu
  • Tao Zhao
  • Jun-Ye Liu
  • Yu-Rong Li
  • Jin Wang
  • Jie Zhang
  • Guo-Zhen Guo
Research Article


Upregulation of translationally controlled tumor protein (TCTP) has been reported in a variety of malignant tumors. However, the impact of TCTP in glioma remains unclear. The objective of this study was to investigate the expression and prognostic value of TCTP in glioma patients. Western blot analysis was used to characterize the expression patterns of TCTP in 45 glioma and 22 normal brain tissues. Immunohistochemistry on a tissue microarray containing 127 cases of glioma was performed to analyze the association between TCTP expression and clinicopathological features. Compared with normal brain tissues, TCTP expression was significantly higher in glioma tissues (p <0.001). In addition, high TCTP expression in glioma was significantly associated with advanced pathological grade (p = 0.018). Kaplan–Meier analysis showed that patients with glioma and higher TCTP expression tend to have shorter overall survival time (p <0.001). In multivariate analysis, TCTP expression was proved to be an independent prognostic factor for patients with glioma (p <0.001). In conclusion, this study confirmed the overexpression of TCTP and its association with tumor progression in glioma. It also provided the first evidence that TCTP expression in glioma was an independent prognostic factor of patients, which might be a potential diagnostic and therapeutic target of glioma.


TCTP Glioma Biomarker Prognosis 



This work was supported by Sponsored Programs: State Key Development Program for Basic Research of China (no. 2011CB503704), State Key Laboratory of Electrical Insulation and Power Equipment (EIPE12210), National Natural Science Foundation of China (nos. 81072272, 51277175, and 31270899), and International Science and Technology Cooperation Projects (no. 2010DFA31900).

Conflicts of interest



  1. 1.
    Rousseau A, Mokhtari K, Duyckaerts C. The 2007 WHO classification of tumors of the central nervous system—what has changed? Cur Open Neural. 2008;21:720–7. doi: 10.1097/WCO.0b013e328312c3a7.CrossRefGoogle Scholar
  2. 2.
    Stylli SS, Howes M, MacGregor L, Rajendra P, Kaye AH. Photodynamic therapy of brain tumors: evaluation of porphyrin uptake versus clinical outcome. J Clan Neurosis. 2004;11:584–96.CrossRefGoogle Scholar
  3. 3.
    Stylli SS, Kaye AH, MacGregor L, Howes M, Rajendra P. Photodynamic therapy of high grade glioma—long term survival. J Clan Neurosis. 2005;12:389–98.CrossRefGoogle Scholar
  4. 4.
    Zhang X, Yang H, Gong B, Jiang C, Yang L. Combined gene expression and protein interaction analysis of dynamic modularity in glioma prognosis. J Neurooncol. 2012;107:281–8. doi: 10.1007/s11060-011-0757-4.PubMedCrossRefGoogle Scholar
  5. 5.
    Böhm H, Benndorf R, Gaestel M, Gross B, Nürnberg P, Kraft R, et al. The growth-related protein P23 of the Ehrlich ascites tumor: translational control, cloning, and primary structure. Biochem Int. 1989;19:277–86.PubMedGoogle Scholar
  6. 6.
    Bonnet C, Perret E, Dumont X, Picard A, Caput D, Lenaers G. Identification and transcription control of fission yeast genes repressed by an ammonium starvation growth arrest. Yeast. 2000;16:23–33.PubMedCrossRefGoogle Scholar
  7. 7.
    MacDonald SM, Rafnar T, Langdon J, Lichtenstein LM. Molecular identification of an IgE-dependent histamine-releasing factor. Science. 1995;269:688–90. doi: 10.1126/science.7542803.PubMedCrossRefGoogle Scholar
  8. 8.
    Chen SH, Wu PS, Chou CH, Yan YT, Liu H, Weng SY, et al. A knockout mouse approach reveals that TCTP functions as an essential factor for cell proliferation and survival in a tissue- or cell type-specific manner. Mol Biol Cell. 2007;18:2525–32. doi: 10.1091/mbc.E07-02-0188.PubMedCrossRefGoogle Scholar
  9. 9.
    Brioudes F, Thierry AM, Chambrier P, Mollereau B, Bendahmane M. Translationally controlled tumor protein is a conserved mitotic growth integrator in animals and plants. Proc Natl Acad Sci U S A. 2010;107:16384–9. doi: 10.1073/pnas.1007926107.PubMedCrossRefGoogle Scholar
  10. 10.
    Tuynder M, Fiucci G, Prieur S, Lespagnol A, Géant A, Beaucourt S, et al. Translationally controlled tumor protein is a target of tumor reversion. Proc Natl Acad Sci U S A. 2004;101:15364–9. doi: 10.1073/pnas.0406776101.PubMedCrossRefGoogle Scholar
  11. 11.
    Li F, Zhang D, Fujise K. Characterization of fortilin, a novel antiapoptotic protein. J Biol Chem. 2001;276:47542–9. doi: 10.1074/jbc.M108954200.PubMedCrossRefGoogle Scholar
  12. 12.
    Liu H, Peng HW, Cheng YS, Yuan HS, Yang-Yen HF. Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP. Mol Cell Biol. 2005;25:3117–26. doi: 10.1128/MCB.25.8.3117-3126.2005.PubMedCrossRefGoogle Scholar
  13. 13.
    Susini L, Besse S, Duflaut D, Lespagnol A, Beekman C, Fiucci G, et al. TCTP protects from apoptotic cell death by antagonizing bax function. Cell Death Differ. 2008;15:1211–20. doi: 10.1038/cdd.2008.18.PubMedCrossRefGoogle Scholar
  14. 14.
    Burgess A, Labbé JC, Vigneron S, Bonneaud N, Strub JM, Van Dorsselaer A, et al. Chfr interacts and colocalizes with TCTP to the mitotic spindle. Oncogene. 2008;27:5554–66. doi: 10.1038/onc.2008.167.PubMedCrossRefGoogle Scholar
  15. 15.
    Tsarova K, Yarmola EG, Bubb MR. Identification of a cofilin-like actin-binding site on translationally controlled tumor protein (TCTP). FEBS Lett. 2010;584:4756–60. doi: 10.1016/j.febslet.2010.10.054.PubMedCrossRefGoogle Scholar
  16. 16.
    Cans C, Passer BJ, Shalak V, Nancy-Portebois V, Crible V, Amzallag N, et al. Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1A. Proc Natl Acad Sci U S A. 2003;100:13892–7. doi: 10.1073/pnas.2335950100.PubMedCrossRefGoogle Scholar
  17. 17.
    Kubiak JZ, Bazile F, Pascal A, Richard-Parpaillon L, Polanski Z, Ciemerych MA, et al. Temporal regulation of embryonic M-phases. Folia Histochem Cytobiol. 2008;46:5–9. doi: 10.2478/v10042-008-0001-z.PubMedGoogle Scholar
  18. 18.
    Hsu YC, Chern JJ, Cai Y, Liu M, Choi KW. Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase. Nature. 2007;445:785–8. doi: 10.1038/nature05528.PubMedCrossRefGoogle Scholar
  19. 19.
    Rho SB, Lee JH, Park MS, Byun HJ, Kang S, Seo SS, et al. Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53. FEBS Lett. 2011;585:29–35. doi: 10.1016/j.febslet.2010.11.014.PubMedCrossRefGoogle Scholar
  20. 20.
    Deng SS, Xing TY, Zhou HY, Xiong RH, Lu YG, Wen B, et al. Comparative proteome analysis of breast cancer and adjacent normal breast tissues in human. Genomics Proteomics Bioinformatics. 2006;4:165–72.PubMedCrossRefGoogle Scholar
  21. 21.
    Wu D, Guo Z, Min W, Zhou B, Li M, Li W, et al. Upregulation of TCTP expression in human skin squamous cell carcinoma increases tumor cell viability through anti-apoptotic action of the protein. Exp Ther Med. 2012;3:437–42. doi: 10.3892/etm.2011.439.PubMedGoogle Scholar
  22. 22.
    Baylot V, Katsogiannou M, Andrieu C, Taieb D, Acunzo J, Giusiano S, et al. Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancer. Mol Ther. 2012;20:2244–56. doi: 10.1038/mt.2012.155.PubMedCrossRefGoogle Scholar
  23. 23.
    Liu L, Zhang CZ, Cai M, Fu J, Chen GG, Yun J. Downregulation of polo-like kinase 4 in hepatocellular carcinoma associates with poor prognosis. PLoS One. 2012;7:e41293. doi: 10.1371/journal.pone.0041293.PubMedCrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  • Xia Miao
    • 1
  • Yong-Bin Chen
    • 1
  • Sheng-Long Xu
    • 1
  • Tao Zhao
    • 1
  • Jun-Ye Liu
    • 1
  • Yu-Rong Li
    • 1
  • Jin Wang
    • 1
  • Jie Zhang
    • 1
  • Guo-Zhen Guo
    • 1
  1. 1.Department of Radiation Medicine, Ministry of Education Key Laboratory of Hazard Assessment and Control in Special Operational EnvironmentSchool of Public Health, Fourth Military Medical UniversityXi’anChina

Personalised recommendations